SCHEMBL10705486

SCHEMBL10705486

C=C1C[C@@H]2[C@H](CC[C@@]3(C)[C@H]2CC[C@]3(OC(=O)CCC)C(C)=O)[C@]2(C)C1=CC(=O)[C@@H]1C[C@@H]12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR3C1 P04150 8/20 0.53
▸ CYP3A4 P08684 7/20 0.53
▸ PGR P06401 7/20 0.53
▸ AR P10275 6/20 0.53
▸ LMNA P02545 5/20 0.53
▸ CYP2C9 P11712 3/20 0.53
▸ MAPT P10636 2/20 0.53
▸ ALDH1A1 P00352 2/20 0.53
▸ CHRM2 P08172 2/20 0.53
▸ MAPK1 P28482 2/20 0.53
▸ TSHR P16473 1/20 0.53
▸ OPRM1 P35372 1/20 0.53
▸ SMN1; SMN2 Q16637 3/20 0.47
▸ NPSR1 Q6W5P4 3/20 0.47
▸ PDE3A Q14432 2/20 0.47
▸ PDE4D Q08499 2/20 0.47
▸ MEN1 O00255 2/20 0.47
▸ KMT2A Q03164 2/20 0.47
▸ HIF1A Q16665 2/20 0.47
▸ HPGD P15428 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10706225 0.96 NR3C1 (0.52) NR3C1CYP3A4PGRARLMNA
SCHEMBL10704394 0.94 CYP3A4 (0.55) NR3C1CYP3A4PGRARLMNA
SCHEMBL10703057 0.93 CYP3A4 (0.54) NR3C1CYP3A4PGRARLMNA
SCHEMBL10703140 0.89 CYP3A4 (0.65) NR3C1CYP3A4PGRARLMNA
SCHEMBL10703728 0.84 CYP3A4 (0.50) NR3C1CYP3A4PGRARLMNA
SCHEMBL10711533 0.84 NR3C1 (0.48) NR3C1CYP3A4PGRARLMNA
SCHEMBL10707423 0.83 NR3C1 (0.59) NR3C1CYP3A4PGRARLMNA
SCHEMBL10705558 0.82 NR3C1 (0.52) NR3C1CYP3A4PGRARLMNA
SCHEMBL10705490 0.80 NR3C1 (0.49) NR3C1CYP3A4PGRARLMNA
SCHEMBL10705817 0.80 CYP3A4 (0.53) NR3C1CYP3A4PGRARLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0153270-B1 1-ALPHA, 2-ALPHA-METHYLENE-6-METHYLENE AND 6-ALPHA-METHYL PREGNENES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM SCHERING AKTIENGESELLSCHAFT (DE) 1988-07-27 — — EP claimed
EP-0153270-A2 1-Alpha, 2-alpha-methylene-6-methylene and 6-alpha-methyl pregnenes, process for their preparation and pharmaceutical compositions containing them SCHERING AKTIENGESELLSCHAFT (DE) 1985-08-28 — — EP claimed
EP-0153270-B1 1-ALPHA, 2-ALPHA-METHYLENE-6-METHYLENE AND 6-ALPHA-METHYL PREGNENES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM SCHERING AKTIENGESELLSCHAFT (DE) 1988-07-27 — — EP disclosed
US-4670427-A ANTIANDROGENS SCHERING AKTIENGESELLSCHAFT (DE) 1987-06-02 — — US disclosed
EP-0153270-A2 1-Alpha, 2-alpha-methylene-6-methylene and 6-alpha-methyl pregnenes, process for their preparation and pharmaceutical compositions containing them SCHERING AKTIENGESELLSCHAFT (DE) 1985-08-28 — — EP disclosed
Send feedback